Lynx2Market (@lynx2market) 's Twitter Profile
Lynx2Market

@lynx2market

ID: 978232062867099650

linkhttp://www.lynx2market.com calendar_today26-03-2018 11:27:53

12 Tweet

6 Followers

72 Following

Lynx2Market (@lynx2market) 's Twitter Profile Photo

The presentations, photos, video and other conference materials will be uploaded by March 19th on our website @ lnkd.in/gupAzYf #BD; #in/out- #licensing; #growthmarkets; #pharmabusinessdevelopment; #go-to-market; #pharmagrowthstrategies; #portfoliodevelopment

The presentations, photos, video and other conference materials will be uploaded by March 19th on our website @ lnkd.in/gupAzYf 
#BD; #in/out- #licensing; #growthmarkets; #pharmabusinessdevelopment; #go-to-market; #pharmagrowthstrategies; #portfoliodevelopment
Lynx2Market (@lynx2market) 's Twitter Profile Photo

Happy New Year to all! Hope you had a lovely winter break! If you are responsible for the BD & Licensing - we are happy to share our excitement for the upcoming PharmaSynergy partnering event that will take place on 24-25 February in London pharma-synergy-conference.com

Happy New Year to all! Hope you had a lovely winter break! 
If you are responsible for the BD & Licensing - we are happy to share our excitement for the upcoming PharmaSynergy partnering event that will take place on 24-25 February in London pharma-synergy-conference.com
Lynx2Market (@lynx2market) 's Twitter Profile Photo

Valeo Pharma Signs Licensing Agreement with Pharmamar to Commercialize Yondelis® in Canada finance.yahoo.com/news/valeo-pha… via Yahoo Finance

Lynx2Market (@lynx2market) 's Twitter Profile Photo

#PharmaSynergy event for the BD&L meetings, February 23-25 The 2021 event will cover two major streams: 1. #PharmaSynergy: Value-added, Niche & Branded Generics & OTC 2. #BioPharmaSynergy: Biosimilar, Biobetters, Bioinnovative medicines pharma-synergy-conference.com

#PharmaSynergy event for the BD&L meetings, February 23-25 

The 2021 event will cover two major streams:
1. #PharmaSynergy: Value-added, Niche & Branded Generics & OTC
2. #BioPharmaSynergy: Biosimilar, Biobetters, Bioinnovative medicines
pharma-synergy-conference.com
Lynx2Market (@lynx2market) 's Twitter Profile Photo

“Cough & cold” and “Calm & Sleep” were the winners of the post-pandemic #over_the_counter_sales and gave a great boost to the #OTC / #CHC-focused companies. What will be the #growth_drivers in the upcoming years? What will be the “next melatonin”? #PharmaSynergyOTC #OTC

“Cough & cold” and “Calm & Sleep” were the winners of the post-pandemic #over_the_counter_sales and gave a great boost to the #OTC / #CHC-focused companies.
What will be the #growth_drivers in the upcoming years? What will be the “next melatonin”?
 
#PharmaSynergyOTC 

#OTC
Lynx2Market (@lynx2market) 's Twitter Profile Photo

Buzzy BD meetings at the PharmaSynergy Conference, Rome, 22-23 March 2018 pharma-synergy-conference.com where dynamic pharma & OTC companies with global growth ambitions from over 20 countries

Lynx2Market (@lynx2market) 's Twitter Profile Photo

Left2right at the PharmaSynergy Conference: Tomasz Kluszczyński, REGIONAL PRINCIPAL, BIOPHARMA LEAD CENTRAL, SOUTH AND EAST EUROPE, RUSSIA & CIS, ISRAEL IQVIA Erez Hybloom, GLOBAL & EUROPE PORTFOLIO, TEVA PHARMACEUTICALS, Kuntal Chatterjee, GLOBAL BUSINESS DEVELOPMENT, APOTEX

Left2right at the PharmaSynergy Conference:
Tomasz Kluszczyński, REGIONAL PRINCIPAL, BIOPHARMA LEAD
 CENTRAL, SOUTH AND EAST EUROPE, RUSSIA & CIS, ISRAEL
 IQVIA
Erez Hybloom, GLOBAL & EUROPE PORTFOLIO, TEVA PHARMACEUTICALS, 
Kuntal Chatterjee, GLOBAL BUSINESS DEVELOPMENT, APOTEX